Browse by category

Structure Therapeutics selects oral small molecule amylin receptor agonist ACCG-2671 for obesity treatment

Structure Therapeutics has selected its lead oral small molecule amylin receptor agonist, ACCG-2671, which the company will develop for...

Survey finds 50% of post-bariatric surgery patients feel less stress during the holidays

35 minutes ago

Journal Watch 18/12/2024

4 hours ago

True You Weight Loss to initiate two clinical trials assessing gastric fundal mucosal ablation

5 hours ago

Weekly Digest